Farallon Capital Management »

NeoGenomics shares owned by Farallon Capital Management

Quarter-by-quarter ownership of NeoGenomics (NEO) shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in NeoGenomics

Tip: Access up to 7 years of quarterly data

All positions including NeoGenomics held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in NeoGenomics by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $223k 19k 11.76
2021-09-30 $26M 530k 48.24
2021-06-30 $19M 420k 45.17

More positions owned by Farallon Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Revolution Medicines (RVMD)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Aon Shs Cl A (AON)
Natera (NTRA)
Boston Scientific Corporation (BSX)
Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option (RSP)
Exelixis (EXEL)
Bridgebio Pharma (BBIO)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Protagonist Therapeutics (PTGX)
Wabtec Corporation (WAB)
UnitedHealth (UNH)
Cyberark Software SHS (CYBR)

View all positions for Farallon Capital Management

Top funds holding NeoGenomics

BlackRock
Vanguard Group
First Light Asset Management
Greenhouse Funds L
Millennium Management
State Street Corporation
Braidwell
Schroder Investment Management Group
Citadel Advisors
D. E. Shaw & Co
Geode Capital Management
Dimensional Fund Advisors
Luke P. La Valle, Jr.
Jennifer Ranahan
T. Rowe Price Investment Management

View all funds holding NeoGenomics